New England Journal of Medicine· 2018Q1
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness
- 580citations
- Q1SCImago
- 2018year
Short summary
In a randomized trial of ICU patients with delirium, neither haloperidol nor ziprasidone significantly improved days alive without delirium or coma over 14 days compared to placebo.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Critical Care and Intensive Care Medicine
Critical Care and Intensive Care MedicineMedicine